

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 4.77011688 |
| 2 | locomotory exploration behavior (GO:0035641) | 4.69169384 |
| 3 | response to peptidoglycan (GO:0032494) | 4.54954442 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.33632632 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.33632632 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 4.33632632 |
| 7 | positive regulation by symbiont of host defense response (GO:0052509) | 4.33632632 |
| 8 | modulation by symbiont of host defense response (GO:0052031) | 4.33632632 |
| 9 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.33632632 |
| 10 | detection of molecule of bacterial origin (GO:0032490) | 4.28057525 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 4.19996849 |
| 12 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.10787632 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.06934277 |
| 14 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.03495945 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.99704082 |
| 16 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.98234404 |
| 17 | negative regulation of cell killing (GO:0031342) | 3.92705109 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.92705109 |
| 19 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.79966474 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 3.69263698 |
| 21 | response to muramyl dipeptide (GO:0032495) | 3.63253864 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.58629197 |
| 23 | sodium ion export (GO:0071436) | 3.58476256 |
| 24 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.57352089 |
| 25 | L-amino acid import (GO:0043092) | 3.56367415 |
| 26 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.55911797 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.55859195 |
| 28 | cellular extravasation (GO:0045123) | 3.55149069 |
| 29 | vocalization behavior (GO:0071625) | 3.52056976 |
| 30 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.48027670 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.47289337 |
| 32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.45817567 |
| 33 | axon ensheathment in central nervous system (GO:0032291) | 3.43002423 |
| 34 | central nervous system myelination (GO:0022010) | 3.43002423 |
| 35 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.33794698 |
| 36 | glycine transport (GO:0015816) | 3.28325173 |
| 37 | neuronal action potential propagation (GO:0019227) | 3.28000257 |
| 38 | synaptic vesicle exocytosis (GO:0016079) | 3.27912176 |
| 39 | germinal center formation (GO:0002467) | 3.27239792 |
| 40 | detection of other organism (GO:0098543) | 3.26861279 |
| 41 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.26289720 |
| 42 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.24381578 |
| 43 | detection of external biotic stimulus (GO:0098581) | 3.22989777 |
| 44 | potassium ion import (GO:0010107) | 3.20687085 |
| 45 | regulation of macrophage cytokine production (GO:0010935) | 3.18319583 |
| 46 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.17764078 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.16493660 |
| 48 | glutamate secretion (GO:0014047) | 3.15986985 |
| 49 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.15853148 |
| 50 | neutrophil activation involved in immune response (GO:0002283) | 3.15647445 |
| 51 | activation of protein kinase A activity (GO:0034199) | 3.13646922 |
| 52 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.13329817 |
| 53 | regulation of synaptic vesicle transport (GO:1902803) | 3.12330928 |
| 54 | macrophage activation (GO:0042116) | 3.12058775 |
| 55 | establishment of nucleus localization (GO:0040023) | 3.11087824 |
| 56 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.10647604 |
| 57 | neuromuscular process controlling balance (GO:0050885) | 3.06021742 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.02586620 |
| 59 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.02042202 |
| 60 | exploration behavior (GO:0035640) | 3.01730727 |
| 61 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01619853 |
| 62 | nerve growth factor signaling pathway (GO:0038180) | 3.01503954 |
| 63 | microglial cell activation (GO:0001774) | 2.99579459 |
| 64 | dendrite morphogenesis (GO:0048813) | 2.97123720 |
| 65 | regulation of ARF protein signal transduction (GO:0032012) | 2.95711432 |
| 66 | leukocyte aggregation (GO:0070486) | 2.93804276 |
| 67 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.93183710 |
| 68 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.92643966 |
| 69 | response to host immune response (GO:0052572) | 2.92643966 |
| 70 | neutrophil mediated immunity (GO:0002446) | 2.90468160 |
| 71 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88381242 |
| 72 | gamma-aminobutyric acid transport (GO:0015812) | 2.87977740 |
| 73 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.86974072 |
| 74 | neurotransmitter secretion (GO:0007269) | 2.86810622 |
| 75 | response to host (GO:0075136) | 2.86551762 |
| 76 | response to host defenses (GO:0052200) | 2.86551762 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.86551762 |
| 78 | cell communication by electrical coupling (GO:0010644) | 2.86279497 |
| 79 | long-term memory (GO:0007616) | 2.81447714 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81083941 |
| 81 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.80355461 |
| 82 | neuron cell-cell adhesion (GO:0007158) | 2.79851888 |
| 83 | amino acid import (GO:0043090) | 2.79406448 |
| 84 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.78236838 |
| 85 | neuronal ion channel clustering (GO:0045161) | 2.76940246 |
| 86 | vesicle transport along microtubule (GO:0047496) | 2.76607165 |
| 87 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.76006916 |
| 88 | synaptic transmission, glutamatergic (GO:0035249) | 2.75084895 |
| 89 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.74417317 |
| 90 | glutamate receptor signaling pathway (GO:0007215) | 2.74122671 |
| 91 | prepulse inhibition (GO:0060134) | 2.74097990 |
| 92 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.73404955 |
| 93 | detection of bacterium (GO:0016045) | 2.72272377 |
| 94 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.72132211 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.68915092 |
| 96 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.68593458 |
| 97 | potassium ion homeostasis (GO:0055075) | 2.68497203 |
| 98 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.67725449 |
| 99 | T-helper 1 type immune response (GO:0042088) | 2.67508056 |
| 100 | myelination (GO:0042552) | 2.67124009 |
| 101 | adult walking behavior (GO:0007628) | 2.67022383 |
| 102 | ensheathment of neurons (GO:0007272) | 2.65439810 |
| 103 | axon ensheathment (GO:0008366) | 2.65439810 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.65336665 |
| 105 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.65251516 |
| 106 | adenosine receptor signaling pathway (GO:0001973) | 2.65095563 |
| 107 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.64341398 |
| 108 | positive regulation of type 2 immune response (GO:0002830) | 2.64120588 |
| 109 | protein localization to synapse (GO:0035418) | 2.62910907 |
| 110 | cerebellar granule cell differentiation (GO:0021707) | 2.62541875 |
| 111 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62361324 |
| 112 | mating behavior (GO:0007617) | 2.61050245 |
| 113 | transmission of nerve impulse (GO:0019226) | 2.60562169 |
| 114 | neuron-neuron synaptic transmission (GO:0007270) | 2.60020284 |
| 115 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.59380441 |
| 116 | regulation of leukocyte degranulation (GO:0043300) | 2.59380437 |
| 117 | positive regulation of receptor recycling (GO:0001921) | 2.59173485 |
| 118 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.59165150 |
| 119 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.58709167 |
| 120 | auditory behavior (GO:0031223) | 2.58612417 |
| 121 | neutrophil activation (GO:0042119) | 2.58085706 |
| 122 | clathrin coat assembly (GO:0048268) | 2.57938961 |
| 123 | regulation of mast cell degranulation (GO:0043304) | 2.57637681 |
| 124 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.56341295 |
| 125 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.56274186 |
| 126 | granulocyte activation (GO:0036230) | 2.56040086 |
| 127 | negative regulation of protein localization to cell surface (GO:2000009) | 2.55808238 |
| 128 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.55158392 |
| 129 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.54897173 |
| 130 | regulation of ARF GTPase activity (GO:0032312) | 2.53556892 |
| 131 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52376762 |
| 132 | protein localization to endosome (GO:0036010) | 2.52057829 |
| 133 | response to auditory stimulus (GO:0010996) | 2.51747387 |
| 134 | regulation of postsynaptic membrane potential (GO:0060078) | 2.51473262 |
| 135 | regulation of type 2 immune response (GO:0002828) | 2.50714923 |
| 136 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.49928857 |
| 137 | myeloid leukocyte mediated immunity (GO:0002444) | 2.49080941 |
| 138 | regulation of synaptic plasticity (GO:0048167) | 2.48725533 |
| 139 | cortical actin cytoskeleton organization (GO:0030866) | 2.48654312 |
| 140 | negative regulation of type 2 immune response (GO:0002829) | 2.48606407 |
| 141 | response to laminar fluid shear stress (GO:0034616) | 2.47669219 |
| 142 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.47017432 |
| 143 | type I interferon signaling pathway (GO:0060337) | 2.46808172 |
| 144 | cellular response to type I interferon (GO:0071357) | 2.46808172 |
| 145 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.46284530 |
| 146 | stress fiber assembly (GO:0043149) | 2.45605581 |
| 147 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.45198632 |
| 148 | membrane depolarization during action potential (GO:0086010) | 2.45098362 |
| 149 | myeloid cell activation involved in immune response (GO:0002275) | 2.44411183 |
| 150 | regulation of dendritic spine development (GO:0060998) | 2.44231094 |
| 151 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.43479107 |
| 152 | synaptic vesicle endocytosis (GO:0048488) | 2.43324110 |
| 153 | response to type I interferon (GO:0034340) | 2.42638026 |
| 154 | negative regulation of T cell mediated immunity (GO:0002710) | 2.42605498 |
| 155 | long-term synaptic potentiation (GO:0060291) | 2.42201544 |
| 156 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.42180609 |
| 157 | neuron recognition (GO:0008038) | 2.41583221 |
| 158 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.41334934 |
| 159 | neuromuscular process controlling posture (GO:0050884) | 2.40708058 |
| 160 | regulation of neurotransmitter secretion (GO:0046928) | 2.40390991 |
| 161 | neutrophil chemotaxis (GO:0030593) | 2.39996720 |
| 162 | positive regulation of membrane potential (GO:0045838) | 2.39830685 |
| 163 | positive regulation of potassium ion transport (GO:0043268) | 2.38661105 |
| 164 | proline transport (GO:0015824) | 2.38455186 |
| 165 | axonal fasciculation (GO:0007413) | 2.37597191 |
| 166 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.37437947 |
| 167 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.37308542 |
| 168 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.36717420 |
| 169 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.36269686 |
| 170 | defense response to protozoan (GO:0042832) | 2.36032156 |
| 171 | regulation of tolerance induction (GO:0002643) | 2.36011858 |
| 172 | membrane hyperpolarization (GO:0060081) | 2.35803880 |
| 173 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.35660507 |
| 174 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.35383723 |
| 175 | neurotransmitter transport (GO:0006836) | 2.35382637 |
| 176 | cellular sodium ion homeostasis (GO:0006883) | 2.35304585 |
| 177 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34697503 |
| 178 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.34550966 |
| 179 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.34464076 |
| 180 | negative regulation of neurotransmitter transport (GO:0051589) | 2.34305487 |
| 181 | negative regulation of interleukin-17 production (GO:0032700) | 2.33539448 |
| 182 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.33424222 |
| 183 | neutrophil migration (GO:1990266) | 2.32835999 |
| 184 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.32775522 |
| 185 | cellular response to epinephrine stimulus (GO:0071872) | 2.31439194 |
| 186 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.28751644 |
| 187 | regulation of interferon-alpha production (GO:0032647) | 2.27078149 |
| 188 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.26832740 |
| 189 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.24974265 |
| 190 | regulation of T cell tolerance induction (GO:0002664) | 2.23721414 |
| 191 | cellular response to ethanol (GO:0071361) | 2.23430420 |
| 192 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.22770942 |
| 193 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.22445645 |
| 194 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.21372556 |
| 195 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.21049972 |
| 196 | positive regulation of interferon-alpha production (GO:0032727) | 2.20836144 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.95171839 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.73260952 |
| 3 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.30747501 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.20427024 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.90828821 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73096891 |
| 7 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.64518750 |
| 8 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.60112707 |
| 9 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56699403 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.49711562 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.49003902 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.48539085 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.48282502 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.43147276 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.43147276 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.41593037 |
| 17 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40312114 |
| 18 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.37692812 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.33098315 |
| 20 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.25931513 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22306029 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.17530634 |
| 23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.16619740 |
| 24 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.15361074 |
| 25 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11581646 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09958990 |
| 27 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.07887006 |
| 28 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.07350109 |
| 29 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03160002 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94142047 |
| 31 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.89384783 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.89189431 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.86569427 |
| 34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.86168570 |
| 35 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85476636 |
| 36 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82929665 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.82237527 |
| 38 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.82153102 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81880212 |
| 40 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.81180699 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.78313772 |
| 42 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.76674393 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72456426 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.70694229 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.65659119 |
| 46 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.64561920 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63659533 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62367054 |
| 49 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.60684943 |
| 50 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.59877762 |
| 51 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.58831248 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.54723761 |
| 53 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53417406 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53113665 |
| 55 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52475407 |
| 56 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49978900 |
| 57 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.47844588 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47731347 |
| 59 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.43073466 |
| 60 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42708875 |
| 61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.41484465 |
| 62 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40667248 |
| 63 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.40634836 |
| 64 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.39395582 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38810090 |
| 66 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.35948023 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.35000315 |
| 68 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.34427278 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34093700 |
| 70 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.33697578 |
| 71 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.32833163 |
| 72 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32795191 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30747212 |
| 74 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.30067667 |
| 75 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30062664 |
| 76 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29641776 |
| 77 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29199621 |
| 78 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.27806465 |
| 79 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27468986 |
| 80 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.26917897 |
| 81 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26354448 |
| 82 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25920649 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25765100 |
| 84 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.25280010 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24523047 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23413742 |
| 87 | * MAF_26560356_Chip-Seq_TH1_Human | 1.22546815 |
| 88 | TP53_16413492_ChIP-PET_HCT116_Human | 1.22182107 |
| 89 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21395683 |
| 90 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.20451556 |
| 91 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.18685957 |
| 92 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.18031772 |
| 93 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.17682812 |
| 94 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.17393273 |
| 95 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.16410123 |
| 96 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16357070 |
| 97 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15622105 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15288968 |
| 99 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.14517694 |
| 100 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13461349 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13297906 |
| 102 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.13110986 |
| 103 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12700895 |
| 104 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.12415046 |
| 105 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12200981 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11142598 |
| 107 | AR_19668381_ChIP-Seq_PC3_Human | 1.09807050 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.09674670 |
| 109 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.09651198 |
| 110 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09469983 |
| 111 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09469983 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.09212841 |
| 113 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08932323 |
| 114 | MYC_22102868_ChIP-Seq_BL_Human | 1.08701961 |
| 115 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.08655409 |
| 116 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.07829842 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 1.07229539 |
| 118 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06332622 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.05677696 |
| 120 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05274932 |
| 121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04125535 |
| 122 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03192826 |
| 123 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02983677 |
| 124 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.02755539 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.02344525 |
| 126 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02283598 |
| 127 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.02005373 |
| 128 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01950382 |
| 129 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.01421789 |
| 130 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.00575614 |
| 131 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.99889207 |
| 132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98663355 |
| 133 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98583194 |
| 134 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98064859 |
| 135 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97714955 |
| 136 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97638651 |
| 137 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97161598 |
| 138 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.96720776 |
| 139 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96448116 |
| 140 | MYB_26560356_Chip-Seq_TH2_Human | 0.96438145 |
| 141 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.94872415 |
| 142 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.94552259 |
| 143 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94388448 |
| 144 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.93105079 |
| 145 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.92224638 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.91907531 |
| 147 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.91706767 |
| 148 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91594696 |
| 149 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.90569425 |
| 150 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90514850 |
| 151 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.90221638 |
| 152 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89935563 |
| 153 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.89850766 |
| 154 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.89335527 |
| 155 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88969338 |
| 156 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.88560417 |
| 157 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.87982772 |
| 158 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.87930520 |
| 159 | GATA2_19941826_ChIP-Seq_K562_Human | 0.87654813 |
| 160 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87452917 |
| 161 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87081230 |
| 162 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86387566 |
| 163 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84055116 |
| 164 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84055116 |
| 165 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83996712 |
| 166 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83945647 |
| 167 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83399114 |
| 168 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.83146866 |
| 169 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80854838 |
| 170 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.79937150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.55718152 |
| 2 | MP0003724_increased_susceptibility_to | 4.05942642 |
| 3 | MP0003436_decreased_susceptibility_to | 3.48058711 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.38370196 |
| 5 | MP0003880_abnormal_central_pattern | 3.20853232 |
| 6 | MP0004270_analgesia | 2.96936440 |
| 7 | MP0009046_muscle_twitch | 2.76293775 |
| 8 | MP0002064_seizures | 2.71745550 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.68789044 |
| 10 | MP0009745_abnormal_behavioral_response | 2.68205923 |
| 11 | MP0000920_abnormal_myelination | 2.63387958 |
| 12 | MP0002063_abnormal_learning/memory/cond | 2.57107040 |
| 13 | MP0002419_abnormal_innate_immunity | 2.48727495 |
| 14 | MP0001486_abnormal_startle_reflex | 2.41736278 |
| 15 | MP0009278_abnormal_bone_marrow | 2.40427021 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.35876397 |
| 17 | MP0006082_CNS_inflammation | 2.33623348 |
| 18 | MP0002272_abnormal_nervous_system | 2.33586807 |
| 19 | MP0003690_abnormal_glial_cell | 2.30854202 |
| 20 | MP0003828_pulmonary_edema | 2.28109525 |
| 21 | MP0005623_abnormal_meninges_morphology | 2.24391620 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.15254136 |
| 23 | MP0004885_abnormal_endolymph | 2.10439404 |
| 24 | MP0008260_abnormal_autophagy | 2.09827539 |
| 25 | MP0002822_catalepsy | 2.09795765 |
| 26 | MP0008569_lethality_at_weaning | 2.09787824 |
| 27 | MP0005167_abnormal_blood-brain_barrier | 2.07057014 |
| 28 | MP0005000_abnormal_immune_tolerance | 2.07049636 |
| 29 | MP0009785_altered_susceptibility_to | 2.05859126 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 2.02961917 |
| 31 | MP0001533_abnormal_skeleton_physiology | 2.02719809 |
| 32 | MP0005025_abnormal_response_to | 1.94281059 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.93142176 |
| 34 | MP0000569_abnormal_digit_pigmentation | 1.92558883 |
| 35 | MP0003329_amyloid_beta_deposits | 1.90502427 |
| 36 | MP0004858_abnormal_nervous_system | 1.89436956 |
| 37 | MP0002734_abnormal_mechanical_nocicepti | 1.80431126 |
| 38 | MP0001501_abnormal_sleep_pattern | 1.75919538 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.75502134 |
| 40 | MP0003191_abnormal_cellular_cholesterol | 1.74634385 |
| 41 | MP0000751_myopathy | 1.71214091 |
| 42 | MP0003634_abnormal_glial_cell | 1.71024187 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.69815426 |
| 44 | MP0001968_abnormal_touch/_nociception | 1.68174273 |
| 45 | MP0006054_spinal_hemorrhage | 1.66158904 |
| 46 | MP0005387_immune_system_phenotype | 1.64800762 |
| 47 | MP0001790_abnormal_immune_system | 1.64800762 |
| 48 | MP0003279_aneurysm | 1.63779442 |
| 49 | MP0002723_abnormal_immune_serum | 1.62871681 |
| 50 | MP0000778_abnormal_nervous_system | 1.62320170 |
| 51 | MP0005171_absent_coat_pigmentation | 1.61865170 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.60099288 |
| 53 | MP0003633_abnormal_nervous_system | 1.60033678 |
| 54 | MP0009764_decreased_sensitivity_to | 1.59361163 |
| 55 | MP0001800_abnormal_humoral_immune | 1.59167737 |
| 56 | MP0004947_skin_inflammation | 1.58501058 |
| 57 | MP0008004_abnormal_stomach_pH | 1.58301750 |
| 58 | MP0002067_abnormal_sensory_capabilities | 1.55924510 |
| 59 | MP0000685_abnormal_immune_system | 1.55407067 |
| 60 | MP0001440_abnormal_grooming_behavior | 1.50455252 |
| 61 | MP0005451_abnormal_body_composition | 1.50020282 |
| 62 | MP0003448_altered_tumor_morphology | 1.48283381 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.47064129 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.46937609 |
| 65 | MP0001819_abnormal_immune_cell | 1.46033839 |
| 66 | MP0000955_abnormal_spinal_cord | 1.46006996 |
| 67 | MP0000343_altered_response_to | 1.42405579 |
| 68 | MP0001545_abnormal_hematopoietic_system | 1.42243211 |
| 69 | MP0005397_hematopoietic_system_phenotyp | 1.42243211 |
| 70 | MP0001970_abnormal_pain_threshold | 1.42203604 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.42002602 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.41755618 |
| 73 | MP0003045_fibrosis | 1.41637669 |
| 74 | MP0002909_abnormal_adrenal_gland | 1.40829424 |
| 75 | MP0003631_nervous_system_phenotype | 1.40255264 |
| 76 | MP0004510_myositis | 1.39697283 |
| 77 | MP0004924_abnormal_behavior | 1.37711309 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.37711309 |
| 79 | MP0003075_altered_response_to | 1.36561749 |
| 80 | MP0002405_respiratory_system_inflammati | 1.35693184 |
| 81 | MP0003632_abnormal_nervous_system | 1.31125588 |
| 82 | MP0005464_abnormal_platelet_physiology | 1.29830555 |
| 83 | MP0002733_abnormal_thermal_nociception | 1.29380526 |
| 84 | MP0005164_abnormal_response_to | 1.26131113 |
| 85 | MP0002882_abnormal_neuron_morphology | 1.26068284 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.25810193 |
| 87 | MP0002066_abnormal_motor_capabilities/c | 1.25020932 |
| 88 | MP0004036_abnormal_muscle_relaxation | 1.24690066 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 1.24611288 |
| 90 | MP0001958_emphysema | 1.24001609 |
| 91 | MP0000013_abnormal_adipose_tissue | 1.23921001 |
| 92 | MP0005076_abnormal_cell_differentiation | 1.23363557 |
| 93 | MP0004742_abnormal_vestibular_system | 1.22435155 |
| 94 | MP0002184_abnormal_innervation | 1.21912846 |
| 95 | MP0003172_abnormal_lysosome_physiology | 1.21702807 |
| 96 | MP0005166_decreased_susceptibility_to | 1.19628361 |
| 97 | MP0002557_abnormal_social/conspecific_i | 1.18663361 |
| 98 | MP0000767_abnormal_smooth_muscle | 1.16347010 |
| 99 | MP0000858_altered_metastatic_potential | 1.15910882 |
| 100 | MP0004215_abnormal_myocardial_fiber | 1.15603009 |
| 101 | MP0001177_atelectasis | 1.15571495 |
| 102 | MP0005671_abnormal_response_to | 1.15187115 |
| 103 | MP0001851_eye_inflammation | 1.10943259 |
| 104 | MP0004808_abnormal_hematopoietic_stem | 1.10594961 |
| 105 | MP0004130_abnormal_muscle_cell | 1.09881823 |
| 106 | MP0005390_skeleton_phenotype | 1.09685138 |
| 107 | MP0001845_abnormal_inflammatory_respons | 1.09020048 |
| 108 | MP0002736_abnormal_nociception_after | 1.08405164 |
| 109 | MP0004085_abnormal_heartbeat | 1.08119478 |
| 110 | MP0003303_peritoneal_inflammation | 1.05480132 |
| 111 | MP0008438_abnormal_cutaneous_collagen | 1.04907662 |
| 112 | MP0002229_neurodegeneration | 1.04122305 |
| 113 | MP0003300_gastrointestinal_ulcer | 1.04096145 |
| 114 | MP0004883_abnormal_blood_vessel | 1.03960692 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 1.03861126 |
| 116 | MP0001299_abnormal_eye_distance/ | 1.03075184 |
| 117 | MP0003221_abnormal_cardiomyocyte_apopto | 1.02915691 |
| 118 | MP0009840_abnormal_foam_cell | 1.02732214 |
| 119 | MP0002735_abnormal_chemical_nociception | 1.02360666 |
| 120 | MP0001502_abnormal_circadian_rhythm | 1.02263321 |
| 121 | MP0000716_abnormal_immune_system | 1.02040006 |
| 122 | MP0001915_intracranial_hemorrhage | 1.01802994 |
| 123 | MP0000604_amyloidosis | 0.99613937 |
| 124 | MP0002090_abnormal_vision | 0.99090501 |
| 125 | MP0003091_abnormal_cell_migration | 0.99066559 |
| 126 | MP0000747_muscle_weakness | 0.98289235 |
| 127 | MP0002152_abnormal_brain_morphology | 0.98141140 |
| 128 | MP0003787_abnormal_imprinting | 0.97458688 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.97038796 |
| 130 | MP0005409_darkened_coat_color | 0.96659214 |
| 131 | MP0003453_abnormal_keratinocyte_physiol | 0.96191217 |
| 132 | MP0005646_abnormal_pituitary_gland | 0.96158254 |
| 133 | MP0008961_abnormal_basal_metabolism | 0.95791461 |
| 134 | MP0006138_congestive_heart_failure | 0.95765358 |
| 135 | MP0004142_abnormal_muscle_tone | 0.95094791 |
| 136 | MP0008469_abnormal_protein_level | 0.93954734 |
| 137 | MP0003137_abnormal_impulse_conducting | 0.93946453 |
| 138 | MP0002398_abnormal_bone_marrow | 0.93782225 |
| 139 | MP0000003_abnormal_adipose_tissue | 0.91222626 |
| 140 | MP0005023_abnormal_wound_healing | 0.89994143 |
| 141 | MP0010352_gastrointestinal_tract_polyps | 0.88822636 |
| 142 | MP0004484_altered_response_of | 0.87683132 |
| 143 | MP0000465_gastrointestinal_hemorrhage | 0.87462441 |
| 144 | MP0004087_abnormal_muscle_fiber | 0.87296392 |
| 145 | MP0008775_abnormal_heart_ventricle | 0.87106338 |
| 146 | MP0005645_abnormal_hypothalamus_physiol | 0.85991740 |
| 147 | MP0001853_heart_inflammation | 0.84160523 |
| 148 | MP0002972_abnormal_cardiac_muscle | 0.83863536 |
| 149 | MP0002837_dystrophic_cardiac_calcinosis | 0.83548937 |
| 150 | MP0008874_decreased_physiological_sensi | 0.82149126 |
| 151 | MP0001485_abnormal_pinna_reflex | 0.82133727 |
| 152 | MP0000249_abnormal_blood_vessel | 0.81501710 |
| 153 | MP0005620_abnormal_muscle_contractility | 0.80526719 |
| 154 | MP0002877_abnormal_melanocyte_morpholog | 0.79714145 |
| 155 | MP0003763_abnormal_thymus_physiology | 0.78171030 |
| 156 | MP0003283_abnormal_digestive_organ | 0.76864697 |
| 157 | MP0005551_abnormal_eye_electrophysiolog | 0.76564458 |
| 158 | MP0002133_abnormal_respiratory_system | 0.76221920 |
| 159 | MP0005388_respiratory_system_phenotype | 0.76221920 |
| 160 | MP0005595_abnormal_vascular_smooth | 0.75795524 |
| 161 | MP0010630_abnormal_cardiac_muscle | 0.72982823 |
| 162 | MP0003879_abnormal_hair_cell | 0.72972688 |
| 163 | MP0003950_abnormal_plasma_membrane | 0.72617756 |
| 164 | MP0002429_abnormal_blood_cell | 0.71834714 |
| 165 | MP0001849_ear_inflammation | 0.71757506 |
| 166 | MP0000733_abnormal_muscle_development | 0.71581550 |
| 167 | MP0003183_abnormal_peptide_metabolism | 0.70338645 |
| 168 | MP0002722_abnormal_immune_system | 0.69283901 |
| 169 | MP0001984_abnormal_olfaction | 0.69045515 |
| 170 | MP0005666_abnormal_adipose_tissue | 0.68980273 |
| 171 | MP0003795_abnormal_bone_structure | 0.68491927 |
| 172 | MP0004272_abnormal_basement_membrane | 0.68203815 |
| 173 | MP0005058_abnormal_lysosome_morphology | 0.67870482 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 4.98972753 |
| 2 | Action tremor (HP:0002345) | 4.28053656 |
| 3 | Focal motor seizures (HP:0011153) | 4.18523451 |
| 4 | Orchitis (HP:0100796) | 4.07886419 |
| 5 | Retrobulbar optic neuritis (HP:0100654) | 3.93106779 |
| 6 | Optic neuritis (HP:0100653) | 3.93106779 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.87032341 |
| 8 | Eczematoid dermatitis (HP:0000976) | 3.86821854 |
| 9 | Myositis (HP:0100614) | 3.83035848 |
| 10 | Focal seizures (HP:0007359) | 3.75823227 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.52432680 |
| 12 | Neurofibrillary tangles (HP:0002185) | 3.40955658 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.36569668 |
| 14 | Ankle clonus (HP:0011448) | 3.31610172 |
| 15 | Peritonitis (HP:0002586) | 3.30560781 |
| 16 | Abnormality of macrophages (HP:0004311) | 3.29440204 |
| 17 | Intention tremor (HP:0002080) | 3.08299909 |
| 18 | Visual hallucinations (HP:0002367) | 3.07593162 |
| 19 | Dysmetria (HP:0001310) | 2.92795524 |
| 20 | Progressive cerebellar ataxia (HP:0002073) | 2.88986561 |
| 21 | Cerebral inclusion bodies (HP:0100314) | 2.87836900 |
| 22 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.85818900 |
| 23 | Dysdiadochokinesis (HP:0002075) | 2.81131078 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 2.79785687 |
| 25 | Postural instability (HP:0002172) | 2.79443580 |
| 26 | Amyloidosis (HP:0011034) | 2.78852021 |
| 27 | Keratoconjunctivitis sicca (HP:0001097) | 2.75498419 |
| 28 | Depression (HP:0000716) | 2.68626389 |
| 29 | Hemiplegia (HP:0002301) | 2.67904902 |
| 30 | Protrusio acetabuli (HP:0003179) | 2.67002247 |
| 31 | Bundle branch block (HP:0011710) | 2.63534240 |
| 32 | Onion bulb formation (HP:0003383) | 2.61804984 |
| 33 | Insidious onset (HP:0003587) | 2.61513723 |
| 34 | Termporal pattern (HP:0011008) | 2.61513723 |
| 35 | Spontaneous hematomas (HP:0007420) | 2.61350644 |
| 36 | Megalencephaly (HP:0001355) | 2.58607239 |
| 37 | Stomatitis (HP:0010280) | 2.57787506 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.54836349 |
| 39 | Spastic gait (HP:0002064) | 2.53115573 |
| 40 | Epileptic encephalopathy (HP:0200134) | 2.50767858 |
| 41 | Mediastinal lymphadenopathy (HP:0100721) | 2.50348075 |
| 42 | Dilatation of the ascending aorta (HP:0005111) | 2.49874087 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 2.48877084 |
| 44 | Scanning speech (HP:0002168) | 2.48253082 |
| 45 | Urinary urgency (HP:0000012) | 2.48169323 |
| 46 | Macroorchidism (HP:0000053) | 2.47722455 |
| 47 | Atonic seizures (HP:0010819) | 2.44579313 |
| 48 | Keratoconjunctivitis (HP:0001096) | 2.43162847 |
| 49 | Abnormality of the corticospinal tract (HP:0002492) | 2.42837785 |
| 50 | Gingivitis (HP:0000230) | 2.40875471 |
| 51 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.40778900 |
| 52 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.40778900 |
| 53 | Broad-based gait (HP:0002136) | 2.40213521 |
| 54 | Lower limb muscle weakness (HP:0007340) | 2.36883299 |
| 55 | Poor eye contact (HP:0000817) | 2.36582516 |
| 56 | Vascular tortuosity (HP:0004948) | 2.35501830 |
| 57 | Generalized tonic-clonic seizures (HP:0002069) | 2.35439768 |
| 58 | Lower limb amyotrophy (HP:0007210) | 2.35215527 |
| 59 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.33963434 |
| 60 | Dysmetric saccades (HP:0000641) | 2.32001280 |
| 61 | Aortic aneurysm (HP:0004942) | 2.31025947 |
| 62 | Truncal ataxia (HP:0002078) | 2.30894194 |
| 63 | Peripheral hypomyelination (HP:0007182) | 2.29750408 |
| 64 | Febrile seizures (HP:0002373) | 2.28719325 |
| 65 | Arterial thrombosis (HP:0004420) | 2.28452984 |
| 66 | Insomnia (HP:0100785) | 2.28286804 |
| 67 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.27379834 |
| 68 | Anxiety (HP:0000739) | 2.27167853 |
| 69 | Broad metatarsal (HP:0001783) | 2.26898231 |
| 70 | Papilledema (HP:0001085) | 2.26547702 |
| 71 | Obstructive sleep apnea (HP:0002870) | 2.26434273 |
| 72 | Cellulitis (HP:0100658) | 2.25966755 |
| 73 | Spondylolisthesis (HP:0003302) | 2.23946626 |
| 74 | Abnormal social behavior (HP:0012433) | 2.23529574 |
| 75 | Impaired social interactions (HP:0000735) | 2.23529574 |
| 76 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.22419334 |
| 77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.21432407 |
| 78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.21432407 |
| 79 | Abnormality of glycolipid metabolism (HP:0010969) | 2.21432407 |
| 80 | Mutism (HP:0002300) | 2.21026646 |
| 81 | Episodic fever (HP:0001954) | 2.20824528 |
| 82 | Hemiparesis (HP:0001269) | 2.18590874 |
| 83 | Neuronal loss in central nervous system (HP:0002529) | 2.16637008 |
| 84 | Torticollis (HP:0000473) | 2.14565596 |
| 85 | Ventricular fibrillation (HP:0001663) | 2.14407740 |
| 86 | Difficulty running (HP:0009046) | 2.12993421 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.12026436 |
| 88 | Diplopia (HP:0000651) | 2.12026436 |
| 89 | Hemoptysis (HP:0002105) | 2.11536692 |
| 90 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.10631962 |
| 91 | Recurrent skin infections (HP:0001581) | 2.10053975 |
| 92 | Abnormality of the endocardium (HP:0004306) | 2.08818899 |
| 93 | Absence seizures (HP:0002121) | 2.07848015 |
| 94 | Prolonged QT interval (HP:0001657) | 2.07775644 |
| 95 | Recurrent fungal infections (HP:0002841) | 2.06460634 |
| 96 | Pointed chin (HP:0000307) | 2.06375620 |
| 97 | Pulmonary infiltrates (HP:0002113) | 2.05237374 |
| 98 | Genetic anticipation (HP:0003743) | 2.04064562 |
| 99 | Chest pain (HP:0100749) | 2.02184177 |
| 100 | Rapidly progressive (HP:0003678) | 2.02022979 |
| 101 | Abnormality of the periventricular white matter (HP:0002518) | 2.01971339 |
| 102 | Dialeptic seizures (HP:0011146) | 2.01411253 |
| 103 | Cerebral aneurysm (HP:0004944) | 2.01115379 |
| 104 | Aneurysm (HP:0002617) | 2.00570055 |
| 105 | Slow saccadic eye movements (HP:0000514) | 2.00531109 |
| 106 | Vasculitis (HP:0002633) | 1.99607194 |
| 107 | Abnormality of the peritoneum (HP:0002585) | 1.99379689 |
| 108 | Aortic dissection (HP:0002647) | 1.98798359 |
| 109 | Subacute progressive viral hepatitis (HP:0006572) | 1.97949565 |
| 110 | Pheochromocytoma (HP:0002666) | 1.97789480 |
| 111 | Hematochezia (HP:0002573) | 1.97697402 |
| 112 | Premature rupture of membranes (HP:0001788) | 1.95600026 |
| 113 | Myocardial infarction (HP:0001658) | 1.93928516 |
| 114 | Mitral valve prolapse (HP:0001634) | 1.93863352 |
| 115 | Muscle fiber splitting (HP:0003555) | 1.93661286 |
| 116 | Upper limb amyotrophy (HP:0009129) | 1.93432343 |
| 117 | Distal upper limb amyotrophy (HP:0007149) | 1.93432343 |
| 118 | Abnormality of saccadic eye movements (HP:0000570) | 1.92433044 |
| 119 | Genu recurvatum (HP:0002816) | 1.90660190 |
| 120 | Atrial fibrillation (HP:0005110) | 1.90256223 |
| 121 | Abnormal eating behavior (HP:0100738) | 1.90238195 |
| 122 | Annular pancreas (HP:0001734) | 1.89681332 |
| 123 | Dysostosis multiplex (HP:0000943) | 1.88860571 |
| 124 | Resting tremor (HP:0002322) | 1.88852957 |
| 125 | Increased cerebral lipofuscin (HP:0011813) | 1.88556230 |
| 126 | Hammertoe (HP:0001765) | 1.88468658 |
| 127 | Pulmonary embolism (HP:0002204) | 1.87889193 |
| 128 | Overriding aorta (HP:0002623) | 1.87882662 |
| 129 | Shallow orbits (HP:0000586) | 1.87136319 |
| 130 | Syringomyelia (HP:0003396) | 1.87133207 |
| 131 | Spinal cord lesions (HP:0100561) | 1.87133207 |
| 132 | Mitral regurgitation (HP:0001653) | 1.86758197 |
| 133 | Progressive inability to walk (HP:0002505) | 1.86736306 |
| 134 | Lower limb asymmetry (HP:0100559) | 1.86519128 |
| 135 | Absent frontal sinuses (HP:0002688) | 1.86467036 |
| 136 | Interstitial pulmonary disease (HP:0006530) | 1.85518013 |
| 137 | Hyporeflexia of lower limbs (HP:0002600) | 1.85186675 |
| 138 | Loss of speech (HP:0002371) | 1.85184189 |
| 139 | Arterial tortuosity (HP:0005116) | 1.84975346 |
| 140 | Increased variability in muscle fiber diameter (HP:0003557) | 1.84027442 |
| 141 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.83839052 |
| 142 | Aplasia of the phalanges of the hand (HP:0009802) | 1.83839052 |
| 143 | Aplasia involving bones of the extremities (HP:0009825) | 1.83839052 |
| 144 | Chronic obstructive pulmonary disease (HP:0006510) | 1.82781797 |
| 145 | Obstructive lung disease (HP:0006536) | 1.82781797 |
| 146 | Sudden death (HP:0001699) | 1.82171402 |
| 147 | Exercise-induced myalgia (HP:0003738) | 1.82061116 |
| 148 | Primary atrial arrhythmia (HP:0001692) | 1.81285786 |
| 149 | Postural tremor (HP:0002174) | 1.79960242 |
| 150 | Hyperacusis (HP:0010780) | 1.79662829 |
| 151 | Excessive salivation (HP:0003781) | 1.77614966 |
| 152 | Drooling (HP:0002307) | 1.77614966 |
| 153 | Scapular winging (HP:0003691) | 1.76619953 |
| 154 | Gingival bleeding (HP:0000225) | 1.76495170 |
| 155 | Apathy (HP:0000741) | 1.75645645 |
| 156 | Increased IgE level (HP:0003212) | 1.75641741 |
| 157 | Decreased motor nerve conduction velocity (HP:0003431) | 1.74604875 |
| 158 | Stereotypic behavior (HP:0000733) | 1.74496072 |
| 159 | Leukocytosis (HP:0001974) | 1.74044378 |
| 160 | Hypoplasia of the iris (HP:0007676) | 1.73896398 |
| 161 | Foot dorsiflexor weakness (HP:0009027) | 1.73758512 |
| 162 | Impaired smooth pursuit (HP:0007772) | 1.73535557 |
| 163 | Buphthalmos (HP:0000557) | 1.73144878 |
| 164 | Clonus (HP:0002169) | 1.73044163 |
| 165 | Meningitis (HP:0001287) | 1.72302377 |
| 166 | Abnormal EKG (HP:0003115) | 1.72165164 |
| 167 | Disinhibition (HP:0000734) | 1.71414945 |
| 168 | Asymmetric septal hypertrophy (HP:0001670) | 1.69937882 |
| 169 | Vertigo (HP:0002321) | 1.69480482 |
| 170 | Vertebral compression fractures (HP:0002953) | 1.68357247 |
| 171 | Urticaria (HP:0001025) | 1.68012434 |
| 172 | Overgrowth (HP:0001548) | 1.66968714 |
| 173 | Disproportionate tall stature (HP:0001519) | 1.64238034 |
| 174 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.62523152 |
| 175 | T lymphocytopenia (HP:0005403) | 1.62410435 |
| 176 | Recurrent cutaneous fungal infections (HP:0011370) | 1.61344627 |
| 177 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.61344627 |
| 178 | Encephalitis (HP:0002383) | 1.60428427 |
| 179 | Polycythemia (HP:0001901) | 1.59514019 |
| 180 | Wormian bones (HP:0002645) | 1.57257844 |
| 181 | Metaphyseal cupping (HP:0003021) | 1.53028217 |
| 182 | Glomerulopathy (HP:0100820) | 1.52683844 |
| 183 | Subaortic stenosis (HP:0001682) | 1.52235411 |
| 184 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.52235411 |
| 185 | Mitral stenosis (HP:0001718) | 1.51645673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 2.78694684 |
| 2 | EPHA4 | 2.75269631 |
| 3 | IRAK3 | 2.75231736 |
| 4 | MAP3K9 | 2.72217159 |
| 5 | PRKD3 | 2.54647807 |
| 6 | PAK6 | 2.37024693 |
| 7 | MAP3K14 | 2.24163635 |
| 8 | MAP2K3 | 2.22466877 |
| 9 | TYK2 | 2.20451374 |
| 10 | BLK | 2.13242080 |
| 11 | KSR2 | 2.02878028 |
| 12 | NTRK1 | 1.99630010 |
| 13 | IRAK4 | 1.98464404 |
| 14 | CSK | 1.97106060 |
| 15 | RIPK1 | 1.92698016 |
| 16 | CAMKK1 | 1.90826436 |
| 17 | WNK1 | 1.89966029 |
| 18 | TRIB3 | 1.85125270 |
| 19 | EPHB1 | 1.84811574 |
| 20 | TYRO3 | 1.81243676 |
| 21 | DAPK2 | 1.78443401 |
| 22 | MAP3K4 | 1.73627130 |
| 23 | MARK1 | 1.67228123 |
| 24 | NTRK2 | 1.65716815 |
| 25 | CAMK1G | 1.57262558 |
| 26 | ZAP70 | 1.55767920 |
| 27 | MAP3K13 | 1.51694035 |
| 28 | STK39 | 1.51470781 |
| 29 | MINK1 | 1.50350517 |
| 30 | DMPK | 1.49388979 |
| 31 | JAK3 | 1.46615010 |
| 32 | PRKCH | 1.45263838 |
| 33 | SGK223 | 1.37616281 |
| 34 | SGK494 | 1.37616281 |
| 35 | RIPK4 | 1.36866441 |
| 36 | CDK5 | 1.36866434 |
| 37 | BMPR2 | 1.34959971 |
| 38 | MOS | 1.34852721 |
| 39 | MAP3K3 | 1.33209555 |
| 40 | JAK2 | 1.31585226 |
| 41 | ERN1 | 1.27437359 |
| 42 | IRAK2 | 1.27312450 |
| 43 | PHKG2 | 1.26239008 |
| 44 | PHKG1 | 1.26239008 |
| 45 | TAOK2 | 1.25531497 |
| 46 | TGFBR2 | 1.25343240 |
| 47 | MAP4K1 | 1.25041316 |
| 48 | STK38 | 1.24902374 |
| 49 | PDGFRA | 1.24343781 |
| 50 | IKBKE | 1.23222513 |
| 51 | TBK1 | 1.22530572 |
| 52 | FES | 1.21019095 |
| 53 | PRPF4B | 1.20878744 |
| 54 | OXSR1 | 1.20831166 |
| 55 | BMX | 1.20718200 |
| 56 | UHMK1 | 1.20284065 |
| 57 | SIK2 | 1.20271064 |
| 58 | CAMK1D | 1.18226016 |
| 59 | LMTK2 | 1.17800107 |
| 60 | RET | 1.14142976 |
| 61 | HCK | 1.13201085 |
| 62 | IRAK1 | 1.12280087 |
| 63 | ALK | 1.11266108 |
| 64 | PAK3 | 1.10267399 |
| 65 | FGFR2 | 1.07759968 |
| 66 | FGFR4 | 1.05002111 |
| 67 | SGK3 | 1.04606947 |
| 68 | MATK | 1.04591928 |
| 69 | PKN1 | 1.04540357 |
| 70 | PTK2B | 1.03339493 |
| 71 | ICK | 1.03325976 |
| 72 | PDPK1 | 1.00774238 |
| 73 | STK11 | 1.00473829 |
| 74 | GRK7 | 1.00311775 |
| 75 | YES1 | 0.98768713 |
| 76 | FGFR3 | 0.98597599 |
| 77 | TIE1 | 0.97983215 |
| 78 | MAPKAPK5 | 0.96535181 |
| 79 | TAOK1 | 0.95935690 |
| 80 | CAMKK2 | 0.95693697 |
| 81 | KSR1 | 0.94112404 |
| 82 | MAP3K6 | 0.92903851 |
| 83 | LATS2 | 0.92610844 |
| 84 | MAP3K2 | 0.90382773 |
| 85 | ROCK2 | 0.89936143 |
| 86 | NEK9 | 0.89897390 |
| 87 | PDK1 | 0.89521179 |
| 88 | TTN | 0.88246316 |
| 89 | MAP2K4 | 0.87254216 |
| 90 | PINK1 | 0.85737900 |
| 91 | MARK2 | 0.84169872 |
| 92 | PDGFRB | 0.84120112 |
| 93 | PRKD1 | 0.81267617 |
| 94 | MAP3K11 | 0.80846153 |
| 95 | NEK6 | 0.79567515 |
| 96 | PLK2 | 0.77775754 |
| 97 | MAPK7 | 0.76253106 |
| 98 | CDK12 | 0.76044279 |
| 99 | SGK2 | 0.75719710 |
| 100 | SYK | 0.75377146 |
| 101 | MAP2K7 | 0.75082590 |
| 102 | SGK1 | 0.73280514 |
| 103 | CDK15 | 0.72766859 |
| 104 | MAPK12 | 0.72357364 |
| 105 | CDK19 | 0.71276996 |
| 106 | EPHA3 | 0.71192033 |
| 107 | CDC42BPA | 0.70849736 |
| 108 | DDR2 | 0.69719304 |
| 109 | CDK14 | 0.69402152 |
| 110 | KIT | 0.68985427 |
| 111 | PTK6 | 0.68711233 |
| 112 | MAP3K5 | 0.67772579 |
| 113 | MAP3K1 | 0.67244312 |
| 114 | CDK18 | 0.66763130 |
| 115 | RAF1 | 0.66290899 |
| 116 | CDK6 | 0.65298900 |
| 117 | FYN | 0.64924540 |
| 118 | BTK | 0.63582106 |
| 119 | CAMK2A | 0.63367884 |
| 120 | PKN2 | 0.63156386 |
| 121 | CAMK1 | 0.62666533 |
| 122 | LYN | 0.61572416 |
| 123 | CAMK2D | 0.60942885 |
| 124 | CAMK2B | 0.60618538 |
| 125 | TNIK | 0.59685279 |
| 126 | JAK1 | 0.59339097 |
| 127 | FGR | 0.58216141 |
| 128 | CDK11A | 0.57902303 |
| 129 | PRKD2 | 0.57527516 |
| 130 | MAP3K7 | 0.57221230 |
| 131 | CAMK4 | 0.56612359 |
| 132 | RPS6KA3 | 0.53783435 |
| 133 | LCK | 0.53585706 |
| 134 | MARK3 | 0.53500400 |
| 135 | TNK2 | 0.52417899 |
| 136 | CSNK1G2 | 0.50763716 |
| 137 | MAPK10 | 0.50197829 |
| 138 | HIPK2 | 0.50082905 |
| 139 | WNK4 | 0.49722663 |
| 140 | SIK3 | 0.49239075 |
| 141 | IKBKB | 0.49005377 |
| 142 | ARAF | 0.47447648 |
| 143 | PRKCE | 0.47344026 |
| 144 | BRD4 | 0.47246100 |
| 145 | ROCK1 | 0.47146831 |
| 146 | MAPK13 | 0.46969074 |
| 147 | DYRK1B | 0.43181126 |
| 148 | PRKCG | 0.42140759 |
| 149 | GRK5 | 0.41693480 |
| 150 | SRC | 0.40483892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Olfactory transduction_Homo sapiens_hsa04740 | 2.22963797 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10971714 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02717443 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.02374261 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01400892 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.99893609 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 1.96613025 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95873753 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91680002 |
| 10 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.87855622 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.77307326 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 1.75360678 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.75135265 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.71057735 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.69127380 |
| 16 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.68207178 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.66842496 |
| 18 | Salivary secretion_Homo sapiens_hsa04970 | 1.66040222 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61778151 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.58992215 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58589202 |
| 22 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.57876265 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.52449472 |
| 24 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.51590469 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.50205848 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.50100708 |
| 27 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47556613 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46046923 |
| 29 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.43353753 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.40415356 |
| 31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.40225626 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39637425 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.37041139 |
| 34 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.35770212 |
| 35 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.35540134 |
| 36 | Long-term depression_Homo sapiens_hsa04730 | 1.35217351 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.32047665 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.32011334 |
| 39 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.31560063 |
| 40 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.28612252 |
| 41 | Measles_Homo sapiens_hsa05162 | 1.28487632 |
| 42 | Pertussis_Homo sapiens_hsa05133 | 1.27773785 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.26218138 |
| 44 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26165116 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 1.26070568 |
| 46 | Cocaine addiction_Homo sapiens_hsa05030 | 1.25279009 |
| 47 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25008473 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.22958060 |
| 49 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.21861945 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.21155943 |
| 51 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20319322 |
| 52 | Gap junction_Homo sapiens_hsa04540 | 1.19522495 |
| 53 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.19118628 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.18044533 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.17616169 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.14626958 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 1.14599525 |
| 58 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.13761110 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.13517097 |
| 60 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.13455921 |
| 61 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10181091 |
| 62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09306865 |
| 63 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.05362592 |
| 64 | Taste transduction_Homo sapiens_hsa04742 | 1.04476464 |
| 65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02274708 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02200488 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02037279 |
| 68 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.01247823 |
| 69 | Hepatitis C_Homo sapiens_hsa05160 | 1.00669124 |
| 70 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.99278867 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.99181931 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93529263 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.92752064 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.91620565 |
| 75 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.90431980 |
| 76 | Endocytosis_Homo sapiens_hsa04144 | 0.88839711 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88748454 |
| 78 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88688464 |
| 79 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.87940943 |
| 80 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87480401 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.87024461 |
| 82 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.85932975 |
| 83 | Melanogenesis_Homo sapiens_hsa04916 | 0.85239897 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.85010218 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83144876 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82758966 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.82446064 |
| 88 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.82279636 |
| 89 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.81797112 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | 0.80466270 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.79781417 |
| 92 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.79372919 |
| 93 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79314346 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78222947 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.78033306 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.75786544 |
| 97 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75577067 |
| 98 | Colorectal cancer_Homo sapiens_hsa05210 | 0.75414776 |
| 99 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75363683 |
| 100 | Apoptosis_Homo sapiens_hsa04210 | 0.74348057 |
| 101 | Platelet activation_Homo sapiens_hsa04611 | 0.74230948 |
| 102 | Allograft rejection_Homo sapiens_hsa05330 | 0.73623198 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73228614 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.71859652 |
| 105 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.69870823 |
| 106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69234955 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.68796055 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.68356960 |
| 109 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68354367 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.68346392 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.66568757 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66094816 |
| 113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.65675661 |
| 114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65238778 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.64990273 |
| 116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.64618464 |
| 117 | Adherens junction_Homo sapiens_hsa04520 | 0.64266728 |
| 118 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.64136905 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.63908987 |
| 120 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.63725581 |
| 121 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.63676325 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63585442 |
| 123 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63210507 |
| 124 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63029505 |
| 125 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62965748 |
| 126 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.62438449 |
| 127 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.61794321 |
| 128 | Endometrial cancer_Homo sapiens_hsa05213 | 0.59793054 |
| 129 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.58700760 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58324360 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58262564 |
| 132 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58147800 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57468360 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.56902093 |
| 135 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55250620 |
| 136 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55236778 |
| 137 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.54901670 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54387789 |
| 139 | Tight junction_Homo sapiens_hsa04530 | 0.52447200 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.49822958 |
| 141 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.49615191 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.48216064 |
| 143 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47783180 |
| 144 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.46335180 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.45768348 |
| 146 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.44206088 |
| 147 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43826171 |
| 148 | Bile secretion_Homo sapiens_hsa04976 | 0.41845196 |

